The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and D-Dimer testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the D-Dimer testing closer to the patient, creating additional opportunities and challenges for suppliers.
This report presents a detailed analysis of the D-Dimer testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 197 pages and 8 tables
SIMILAR MARKET STUDIES
2016 Future Horizons and Growth Strategies in the Spanish Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.“2016 Future Horizons and Growth Strategies in the Spanish Clinical Chemistry and Immunodiagnostic Markets” is a new strategic analysis of major business opportunities emerging in the Spanish clinical chemistry and immunodiagnostic markets during the next five years. The report explores future ...
October 2015 | $3950 | View Details >>
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs. Scope of the Report: This report focuses on the Spine Biologics in Global ...
August 2016 | $3480 | View Details >>
This report studies sales (consumption) of Continuous Renal Replacement Therapy (CRRT) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering BAXTER INTERNATIONAL GAMBRO BAXTER B. BRAUN MELSUNGEN AG NXSTAGE MEDICAL, INC. ASAHI KASEI MEDICAL CO., LTD. CENTRAL ADMIXTURE PHARMACY SERVICES, ...
August 2016 | $3800 | View Details >>
Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. “2015 Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside” is VPGMarketResearch’s new seven-country report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities ...
June 2015 | $15900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research